Summary
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
According to APO Research, The global Follicle Stimulating Hormone market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Follicle Stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Follicle Stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Follicle Stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Follicle Stimulating Hormone is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Follicle Stimulating Hormone include Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter and Teva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Follicle Stimulating Hormone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Follicle Stimulating Hormone, also provides the sales of main regions and countries. Of the upcoming market potential for Follicle Stimulating Hormone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Follicle Stimulating Hormone sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Follicle Stimulating Hormone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Follicle Stimulating Hormone sales, projected growth trends, production technology, application and end-user industry.
Follicle Stimulating Hormone segment by Company
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Follicle Stimulating Hormone segment by Type
Recombinant FSH
Urinary FSH
Follicle Stimulating Hormone segment by Application
Infertility Treatment
Assisted Reproductive Technology
Follicle Stimulating Hormone segment by Region
North America
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Follicle Stimulating Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Follicle Stimulating Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Follicle Stimulating Hormone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Follicle Stimulating Hormone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Follicle Stimulating Hormone sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Follicle Stimulating Hormone Market by Type
1.2.1 Global Follicle Stimulating Hormone Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Recombinant FSH
1.2.3 Urinary FSH
1.3 Follicle Stimulating Hormone Market by Application
1.3.1 Global Follicle Stimulating Hormone Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Infertility Treatment
1.3.3 Assisted Reproductive Technology
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Follicle Stimulating Hormone Market Dynamics
2.1 Follicle Stimulating Hormone Industry Trends
2.2 Follicle Stimulating Hormone Industry Drivers
2.3 Follicle Stimulating Hormone Industry Opportunities and Challenges
2.4 Follicle Stimulating Hormone Industry Restraints
3 Global Market Growth Prospects
3.1 Global Follicle Stimulating Hormone Revenue Estimates and Forecasts (2019-2030)
3.2 Global Follicle Stimulating Hormone Revenue by Region
3.2.1 Global Follicle Stimulating Hormone Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Follicle Stimulating Hormone Revenue by Region (2019-2024)
3.2.3 Global Follicle Stimulating Hormone Revenue by Region (2025-2030)
3.2.4 Global Follicle Stimulating Hormone Revenue Market Share by Region (2019-2030)
3.3 Global Follicle Stimulating Hormone Sales Estimates and Forecasts 2019-2030
3.4 Global Follicle Stimulating Hormone Sales by Region
3.4.1 Global Follicle Stimulating Hormone Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Follicle Stimulating Hormone Sales by Region (2019-2024)
3.4.3 Global Follicle Stimulating Hormone Sales by Region (2025-2030)
3.4.4 Global Follicle Stimulating Hormone Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Follicle Stimulating Hormone Revenue by Manufacturers
4.1.1 Global Follicle Stimulating Hormone Revenue by Manufacturers (2019-2024)
4.1.2 Global Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Follicle Stimulating Hormone Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Follicle Stimulating Hormone Sales by Manufacturers
4.2.1 Global Follicle Stimulating Hormone Sales by Manufacturers (2019-2024)
4.2.2 Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Follicle Stimulating Hormone Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Follicle Stimulating Hormone Sales Price by Manufacturers (2019-2024)
4.4 Global Follicle Stimulating Hormone Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Follicle Stimulating Hormone Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Follicle Stimulating Hormone Manufacturers, Product Type & Application
4.7 Global Follicle Stimulating Hormone Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Follicle Stimulating Hormone Market CR5 and HHI
4.8.2 2023 Follicle Stimulating Hormone Tier 1, Tier 2, and Tier 3
5 Follicle Stimulating Hormone Market by Type
5.1 Global Follicle Stimulating Hormone Revenue by Type
5.1.1 Global Follicle Stimulating Hormone Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Follicle Stimulating Hormone Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Follicle Stimulating Hormone Revenue Market Share by Type (2019-2030)
5.2 Global Follicle Stimulating Hormone Sales by Type
5.2.1 Global Follicle Stimulating Hormone Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Follicle Stimulating Hormone Sales by Type (2019-2030) & (K Doses)
5.2.3 Global Follicle Stimulating Hormone Sales Market Share by Type (2019-2030)
5.3 Global Follicle Stimulating Hormone Price by Type
6 Follicle Stimulating Hormone Market by Application
6.1 Global Follicle Stimulating Hormone Revenue by Application
6.1.1 Global Follicle Stimulating Hormone Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Follicle Stimulating Hormone Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Follicle Stimulating Hormone Revenue Market Share by Application (2019-2030)
6.2 Global Follicle Stimulating Hormone Sales by Application
6.2.1 Global Follicle Stimulating Hormone Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Follicle Stimulating Hormone Sales by Application (2019-2030) & (K Doses)
6.2.3 Global Follicle Stimulating Hormone Sales Market Share by Application (2019-2030)
6.3 Global Follicle Stimulating Hormone Price by Application
7 Company Profiles
7.1 Merck Serono
7.1.1 Merck Serono Comapny Information
7.1.2 Merck Serono Business Overview
7.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Merck Serono Follicle Stimulating Hormone Product Portfolio
7.1.5 Merck Serono Recent Developments
7.2 MSD
7.2.1 MSD Comapny Information
7.2.2 MSD Business Overview
7.2.3 MSD Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 MSD Follicle Stimulating Hormone Product Portfolio
7.2.5 MSD Recent Developments
7.3 IBSA
7.3.1 IBSA Comapny Information
7.3.2 IBSA Business Overview
7.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 IBSA Follicle Stimulating Hormone Product Portfolio
7.3.5 IBSA Recent Developments
7.4 Ferring
7.4.1 Ferring Comapny Information
7.4.2 Ferring Business Overview
7.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Ferring Follicle Stimulating Hormone Product Portfolio
7.4.5 Ferring Recent Developments
7.5 Livzon
7.5.1 Livzon Comapny Information
7.5.2 Livzon Business Overview
7.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Livzon Follicle Stimulating Hormone Product Portfolio
7.5.5 Livzon Recent Developments
7.6 Techwell
7.6.1 Techwell Comapny Information
7.6.2 Techwell Business Overview
7.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Techwell Follicle Stimulating Hormone Product Portfolio
7.6.5 Techwell Recent Developments
7.7 GenSci
7.7.1 GenSci Comapny Information
7.7.2 GenSci Business Overview
7.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 GenSci Follicle Stimulating Hormone Product Portfolio
7.7.5 GenSci Recent Developments
7.8 Gedeon Richter
7.8.1 Gedeon Richter Comapny Information
7.8.2 Gedeon Richter Business Overview
7.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Gedeon Richter Follicle Stimulating Hormone Product Portfolio
7.8.5 Gedeon Richter Recent Developments
7.9 Teva
7.9.1 Teva Comapny Information
7.9.2 Teva Business Overview
7.9.3 Teva Follicle Stimulating Hormone Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Teva Follicle Stimulating Hormone Product Portfolio
7.9.5 Teva Recent Developments
8 North America
8.1 North America Follicle Stimulating Hormone Market Size by Type
8.1.1 North America Follicle Stimulating Hormone Revenue by Type (2019-2030)
8.1.2 North America Follicle Stimulating Hormone Sales by Type (2019-2030)
8.1.3 North America Follicle Stimulating Hormone Price by Type (2019-2030)
8.2 North America Follicle Stimulating Hormone Market Size by Application
8.2.1 North America Follicle Stimulating Hormone Revenue by Application (2019-2030)
8.2.2 North America Follicle Stimulating Hormone Sales by Application (2019-2030)
8.2.3 North America Follicle Stimulating Hormone Price by Application (2019-2030)
8.3 North America Follicle Stimulating Hormone Market Size by Country
8.3.1 North America Follicle Stimulating Hormone Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Follicle Stimulating Hormone Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Follicle Stimulating Hormone Price by Country (2019-2030)
9 Europe
9.1 Europe Follicle Stimulating Hormone Market Size by Type
9.1.1 Europe Follicle Stimulating Hormone Revenue by Type (2019-2030)
9.1.2 Europe Follicle Stimulating Hormone Sales by Type (2019-2030)
9.1.3 Europe Follicle Stimulating Hormone Price by Type (2019-2030)
9.2 Europe Follicle Stimulating Hormone Market Size by Application
9.2.1 Europe Follicle Stimulating Hormone Revenue by Application (2019-2030)
9.2.2 Europe Follicle Stimulating Hormone Sales by Application (2019-2030)
9.2.3 Europe Follicle Stimulating Hormone Price by Application (2019-2030)
9.3 Europe Follicle Stimulating Hormone Market Size by Country
9.3.1 Europe Follicle Stimulating Hormone Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Follicle Stimulating Hormone Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Follicle Stimulating Hormone Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Follicle Stimulating Hormone Market Size by Type
10.1.1 China Follicle Stimulating Hormone Revenue by Type (2019-2030)
10.1.2 China Follicle Stimulating Hormone Sales by Type (2019-2030)
10.1.3 China Follicle Stimulating Hormone Price by Type (2019-2030)
10.2 China Follicle Stimulating Hormone Market Size by Application
10.2.1 China Follicle Stimulating Hormone Revenue by Application (2019-2030)
10.2.2 China Follicle Stimulating Hormone Sales by Application (2019-2030)
10.2.3 China Follicle Stimulating Hormone Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Follicle Stimulating Hormone Market Size by Type
11.1.1 Asia Follicle Stimulating Hormone Revenue by Type (2019-2030)
11.1.2 Asia Follicle Stimulating Hormone Sales by Type (2019-2030)
11.1.3 Asia Follicle Stimulating Hormone Price by Type (2019-2030)
11.2 Asia Follicle Stimulating Hormone Market Size by Application
11.2.1 Asia Follicle Stimulating Hormone Revenue by Application (2019-2030)
11.2.2 Asia Follicle Stimulating Hormone Sales by Application (2019-2030)
11.2.3 Asia Follicle Stimulating Hormone Price by Application (2019-2030)
11.3 Asia Follicle Stimulating Hormone Market Size by Country
11.3.1 Asia Follicle Stimulating Hormone Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Follicle Stimulating Hormone Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Follicle Stimulating Hormone Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Follicle Stimulating Hormone Market Size by Type
12.1.1 MEALA Follicle Stimulating Hormone Revenue by Type (2019-2030)
12.1.2 MEALA Follicle Stimulating Hormone Sales by Type (2019-2030)
12.1.3 MEALA Follicle Stimulating Hormone Price by Type (2019-2030)
12.2 MEALA Follicle Stimulating Hormone Market Size by Application
12.2.1 MEALA Follicle Stimulating Hormone Revenue by Application (2019-2030)
12.2.2 MEALA Follicle Stimulating Hormone Sales by Application (2019-2030)
12.2.3 MEALA Follicle Stimulating Hormone Price by Application (2019-2030)
12.3 MEALA Follicle Stimulating Hormone Market Size by Country
12.3.1 MEALA Follicle Stimulating Hormone Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Follicle Stimulating Hormone Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Follicle Stimulating Hormone Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Follicle Stimulating Hormone Value Chain Analysis
13.1.1 Follicle Stimulating Hormone Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Follicle Stimulating Hormone Production Mode & Process
13.2 Follicle Stimulating Hormone Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Follicle Stimulating Hormone Distributors
13.2.3 Follicle Stimulating Hormone Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Follicle Stimulating Hormone Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Recombinant FSH Major Manufacturers
Table 3. Urinary FSH Major Manufacturers
Table 4. Global Follicle Stimulating Hormone Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Infertility Treatment Major Manufacturers
Table 6. Assisted Reproductive Technology Major Manufacturers
Table 7. Follicle Stimulating Hormone Industry Trends
Table 8. Follicle Stimulating Hormone Industry Drivers
Table 9. Follicle Stimulating Hormone Industry Opportunities and Challenges
Table 10. Follicle Stimulating Hormone Industry Restraints
Table 11. Global Follicle Stimulating Hormone Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Follicle Stimulating Hormone Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Follicle Stimulating Hormone Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Follicle Stimulating Hormone Revenue Market Share by Region (2019-2024)
Table 15. Global Follicle Stimulating Hormone Revenue Market Share by Region (2025-2030)
Table 16. Global Follicle Stimulating Hormone Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Doses)
Table 17. Global Follicle Stimulating Hormone Sales by Region (2019-2024) & (K Doses)
Table 18. Global Follicle Stimulating Hormone Sales by Region (2025-2030) & (K Doses)
Table 19. Global Follicle Stimulating Hormone Sales Market Share by Region (2019-2024)
Table 20. Global Follicle Stimulating Hormone Sales Market Share by Region (2025-2030)
Table 21. Global Follicle Stimulating Hormone Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Follicle Stimulating Hormone Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Follicle Stimulating Hormone Sales Price (USD/Dose) of Manufacturers (2019-2024)
Table 26. Global Follicle Stimulating Hormone Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Follicle Stimulating Hormone Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Follicle Stimulating Hormone Manufacturers, Product Type & Application
Table 29. Global Follicle Stimulating Hormone Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Follicle Stimulating Hormone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Follicle Stimulating Hormone Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Follicle Stimulating Hormone Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Follicle Stimulating Hormone Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Follicle Stimulating Hormone Revenue Market Share by Type (2019-2024)
Table 36. Global Follicle Stimulating Hormone Revenue Market Share by Type (2025-2030)
Table 37. Global Follicle Stimulating Hormone Sales by Type 2019 VS 2023 VS 2030 (K Doses)
Table 38. Global Follicle Stimulating Hormone Sales by Type (2019-2024) & (K Doses)
Table 39. Global Follicle Stimulating Hormone Sales by Type (2025-2030) & (K Doses)
Table 40. Global Follicle Stimulating Hormone Sales Market Share by Type (2019-2024)
Table 41. Global Follicle Stimulating Hormone Sales Market Share by Type (2025-2030)
Table 42. Global Follicle Stimulating Hormone Price by Type (2019-2024) & (USD/Dose)
Table 43. Global Follicle Stimulating Hormone Price by Type (2025-2030) & (USD/Dose)
Table 44. Global Follicle Stimulating Hormone Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Follicle Stimulating Hormone Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Follicle Stimulating Hormone Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Follicle Stimulating Hormone Revenue Market Share by Application (2019-2024)
Table 48. Global Follicle Stimulating Hormone Revenue Market Share by Application (2025-2030)
Table 49. Global Follicle Stimulating Hormone Sales by Application 2019 VS 2023 VS 2030 (K Doses)
Table 50. Global Follicle Stimulating Hormone Sales by Application (2019-2024) & (K Doses)
Table 51. Global Follicle Stimulating Hormone Sales by Application (2025-2030) & (K Doses)
Table 52. Global Follicle Stimulating Hormone Sales Market Share by Application (2019-2024)
Table 53. Global Follicle Stimulating Hormone Sales Market Share by Application (2025-2030)
Table 54. Global Follicle Stimulating Hormone Price by Application (2019-2024) & (USD/Dose)
Table 55. Global Follicle Stimulating Hormone Price by Application (2025-2030) & (USD/Dose)
Table 56. Merck Serono Company Information
Table 57. Merck Serono Business Overview
Table 58. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 59. Merck Serono Follicle Stimulating Hormone Product Portfolio
Table 60. Merck Serono Recent Development
Table 61. MSD Company Information
Table 62. MSD Business Overview
Table 63. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 64. MSD Follicle Stimulating Hormone Product Portfolio
Table 65. MSD Recent Development
Table 66. IBSA Company Information
Table 67. IBSA Business Overview
Table 68. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 69. IBSA Follicle Stimulating Hormone Product Portfolio
Table 70. IBSA Recent Development
Table 71. Ferring Company Information
Table 72. Ferring Business Overview
Table 73. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 74. Ferring Follicle Stimulating Hormone Product Portfolio
Table 75. Ferring Recent Development
Table 76. Livzon Company Information
Table 77. Livzon Business Overview
Table 78. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 79. Livzon Follicle Stimulating Hormone Product Portfolio
Table 80. Livzon Recent Development
Table 81. Techwell Company Information
Table 82. Techwell Business Overview
Table 83. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 84. Techwell Follicle Stimulating Hormone Product Portfolio
Table 85. Techwell Recent Development
Table 86. GenSci Company Information
Table 87. GenSci Business Overview
Table 88. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 89. GenSci Follicle Stimulating Hormone Product Portfolio
Table 90. GenSci Recent Development
Table 91. Gedeon Richter Company Information
Table 92. Gedeon Richter Business Overview
Table 93. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 94. Gedeon Richter Follicle Stimulating Hormone Product Portfolio
Table 95. Gedeon Richter Recent Development
Table 96. Teva Company Information
Table 97. Teva Business Overview
Table 98. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 99. Teva Follicle Stimulating Hormone Product Portfolio
Table 100. Teva Recent Development
Table 101. North America Follicle Stimulating Hormone Revenue by Type (2019-2024) & (US$ Million)
Table 102. North America Follicle Stimulating Hormone Revenue by Type (2025-2030) & (US$ Million)
Table 103. North America Follicle Stimulating Hormone Sales by Type (2019-2024) & (K Doses)
Table 104. North America Follicle Stimulating Hormone Sales by Type (2025-2030) & (K Doses)
Table 105. North America Follicle Stimulating Hormone Sales Price by Type (2019-2024) & (USD/Dose)
Table 106. North America Follicle Stimulating Hormone Sales Price by Type (2025-2030) & (USD/Dose)
Table 107. North America Follicle Stimulating Hormone Revenue by Application (2019-2024) & (US$ Million)
Table 108. North America Follicle Stimulating Hormone Revenue by Application (2025-2030) & (US$ Million)
Table 109. North America Follicle Stimulating Hormone Sales by Application (2019-2024) & (K Doses)
Table 110. North America Follicle Stimulating Hormone Sales by Application (2025-2030) & (K Doses)
Table 111. North America Follicle Stimulating Hormone Sales Price by Application (2019-2024) & (USD/Dose)
Table 112. North America Follicle Stimulating Hormone Sales Price by Application (2025-2030) & (USD/Dose)
Table 113. North America Follicle Stimulating Hormone Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. North America Follicle Stimulating Hormone Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 115. North America Follicle Stimulating Hormone Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 116. North America Follicle Stimulating Hormone Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 117. North America Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 118. North America Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 119. North America Follicle Stimulating Hormone Sales Price by Country (2019-2024) & (USD/Dose)
Table 120. North America Follicle Stimulating Hormone Sales Price by Country (2025-2030) & (USD/Dose)
Table 121. US Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 122. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 123. Europe Follicle Stimulating Hormone Revenue by Type (2019-2024) & (US$ Million)
Table 124. Europe Follicle Stimulating Hormone Revenue by Type (2025-2030) & (US$ Million)
Table 125. Europe Follicle Stimulating Hormone Sales by Type (2019-2024) & (K Doses)
Table 126. Europe Follicle Stimulating Hormone Sales by Type (2025-2030) & (K Doses)
Table 127. Europe Follicle Stimulating Hormone Sales Price by Type (2019-2024) & (USD/Dose)
Table 128. Europe Follicle Stimulating Hormone Sales Price by Type (2025-2030) & (USD/Dose)
Table 129. Europe Follicle Stimulating Hormone Revenue by Application (2019-2024) & (US$ Million)
Table 130. Europe Follicle Stimulating Hormone Revenue by Application (2025-2030) & (US$ Million)
Table 131. Europe Follicle Stimulating Hormone Sales by Application (2019-2024) & (K Doses)
Table 132. Europe Follicle Stimulating Hormone Sales by Application (2025-2030) & (K Doses)
Table 133. Europe Follicle Stimulating Hormone Sales Price by Application (2019-2024) & (USD/Dose)
Table 134. Europe Follicle Stimulating Hormone Sales Price by Application (2025-2030) & (USD/Dose)
Table 135. Europe Follicle Stimulating Hormone Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 136. Europe Follicle Stimulating Hormone Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 137. Europe Follicle Stimulating Hormone Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 138. Europe Follicle Stimulating Hormone Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 139. Europe Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 140. Europe Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 141. Europe Follicle Stimulating Hormone Sales Price by Country (2019-2024) & (USD/Dose)
Table 142. Europe Follicle Stimulating Hormone Sales Price by Country (2025-2030) & (USD/Dose)
Table 143. Germany Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 144. France Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 145. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 146. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 147. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 148. China Follicle Stimulating Hormone Revenue by Type (2019-2024) & (US$ Million)
Table 149. China Follicle Stimulating Hormone Revenue by Type (2025-2030) & (US$ Million)
Table 150. China Follicle Stimulating Hormone Sales by Type (2019-2024) & (K Doses)
Table 151. China Follicle Stimulating Hormone Sales by Type (2025-2030) & (K Doses)
Table 152. China Follicle Stimulating Hormone Sales Price by Type (2019-2024) & (USD/Dose)
Table 153. China Follicle Stimulating Hormone Sales Price by Type (2025-2030) & (USD/Dose)
Table 154. China Follicle Stimulating Hormone Revenue by Application (2019-2024) & (US$ Million)
Table 155. China Follicle Stimulating Hormone Revenue by Application (2025-2030) & (US$ Million)
Table 156. China Follicle Stimulating Hormone Sales by Application (2019-2024) & (K Doses)
Table 157. China Follicle Stimulating Hormone Sales by Application (2025-2030) & (K Doses)
Table 158. China Follicle Stimulating Hormone Sales Price by Application (2019-2024) & (USD/Dose)
Table 159. China Follicle Stimulating Hormone Sales Price by Application (2025-2030) & (USD/Dose)
Table 160. Asia Follicle Stimulating Hormone Revenue by Type (2019-2024) & (US$ Million)
Table 161. Asia Follicle Stimulating Hormone Revenue by Type (2025-2030) & (US$ Million)
Table 162. Asia Follicle Stimulating Hormone Sales by Type (2019-2024) & (K Doses)
Table 163. Asia Follicle Stimulating Hormone Sales by Type (2025-2030) & (K Doses)
Table 164. Asia Follicle Stimulating Hormone Sales Price by Type (2019-2024) & (USD/Dose)
Table 165. Asia Follicle Stimulating Hormone Sales Price by Type (2025-2030) & (USD/Dose)
Table 166. Asia Follicle Stimulating Hormone Revenue by Application (2019-2024) & (US$ Million)
Table 167. Asia Follicle Stimulating Hormone Revenue by Application (2025-2030) & (US$ Million)
Table 168. Asia Follicle Stimulating Hormone Sales by Application (2019-2024) & (K Doses)
Table 169. Asia Follicle Stimulating Hormone Sales by Application (2025-2030) & (K Doses)
Table 170. Asia Follicle Stimulating Hormone Sales Price by Application (2019-2024) & (USD/Dose)
Table 171. Asia Follicle Stimulating Hormone Sales Price by Application (2025-2030) & (USD/Dose)
Table 172. Asia Follicle Stimulating Hormone Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 173. Asia Follicle Stimulating Hormone Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 174. Asia Follicle Stimulating Hormone Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 175. Asia Follicle Stimulating Hormone Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 176. Asia Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 177. Asia Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 178. Asia Follicle Stimulating Hormone Sales Price by Country (2019-2024) & (USD/Dose)
Table 179. Asia Follicle Stimulating Hormone Sales Price by Country (2025-2030) & (USD/Dose)
Table 180. Japan Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 181. South Korea Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 182. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 183. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 184. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 185. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 186. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 187. Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 188. MEALA Follicle Stimulating Hormone Revenue by Type (2019-2024) & (US$ Million)
Table 189. MEALA Follicle Stimulating Hormone Revenue by Type (2025-2030) & (US$ Million)
Table 190. MEALA Follicle Stimulating Hormone Sales by Type (2019-2024) & (K Doses)
Table 191. MEALA Follicle Stimulating Hormone Sales by Type (2025-2030) & (K Doses)
Table 192. MEALA Follicle Stimulating Hormone Sales Price by Type (2019-2024) & (USD/Dose)
Table 193. MEALA Follicle Stimulating Hormone Sales Price by Type (2025-2030) & (USD/Dose)
Table 194. MEALA Follicle Stimulating Hormone Revenue by Application (2019-2024) & (US$ Million)
Table 195. MEALA Follicle Stimulating Hormone Revenue by Application (2025-2030) & (US$ Million)
Table 196. MEALA Follicle Stimulating Hormone Sales by Application (2019-2024) & (K Doses)
Table 197. MEALA Follicle Stimulating Hormone Sales by Application (2025-2030) & (K Doses)
Table 198. MEALA Follicle Stimulating Hormone Sales Price by Application (2019-2024) & (USD/Dose)
Table 199. MEALA Follicle Stimulating Hormone Sales Price by Application (2025-2030) & (USD/Dose)
Table 200. MEALA Follicle Stimulating Hormone Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 201. MEALA Follicle Stimulating Hormone Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 202. MEALA Follicle Stimulating Hormone Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 203. MEALA Follicle Stimulating Hormone Sales by Country (2019 VS 2023 VS 2030) & (K Doses)
Table 204. MEALA Follicle Stimulating Hormone Sales by Country (2019-2024) & (K Doses)
Table 205. MEALA Follicle Stimulating Hormone Sales by Country (2025-2030) & (K Doses)
Table 206. MEALA Follicle Stimulating Hormone Sales Price by Country (2019-2024) & (USD/Dose)
Table 207. MEALA Follicle Stimulating Hormone Sales Price by Country (2025-2030) & (USD/Dose)
Table 208. Mexico Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 209. Brazil Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 210. Israel Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 211. Argentina Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 212. Colombia Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 213. Turkey Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 214. Saudi Arabia Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 215. UAE Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Table 216. Key Raw Materials
Table 217. Raw Materials Key Suppliers
Table 218. Follicle Stimulating Hormone Distributors List
Table 219. Follicle Stimulating Hormone Customers List
Table 220. Research Programs/Design for This Report
Table 221. Authors List of This Report
Table 222. Secondary Sources
Table 223. Primary Sources
List of Figures
Figure 1. Follicle Stimulating Hormone Product Picture
Figure 2. Global Follicle Stimulating Hormone Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Follicle Stimulating Hormone Market Size Share 2019 VS 2023 VS 2030
Figure 4. Recombinant FSH Picture
Figure 5. Urinary FSH Picture
Figure 6. Global Follicle Stimulating Hormone Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Follicle Stimulating Hormone Market Size Share 2019 VS 2023 VS 2030
Figure 8. Infertility Treatment Picture
Figure 9. Assisted Reproductive Technology Picture
Figure 10. Global Follicle Stimulating Hormone Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Follicle Stimulating Hormone Revenue (2019-2030) & (US$ Million)
Figure 12. Global Follicle Stimulating Hormone Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Follicle Stimulating Hormone Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Follicle Stimulating Hormone Revenue Market Share by Region (2019-2030)
Figure 15. Global Follicle Stimulating Hormone Sales (2019-2030) & (K Doses)
Figure 16. Global Follicle Stimulating Hormone Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Doses)
Figure 17. Global Follicle Stimulating Hormone Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Follicle Stimulating Hormone Sales YoY (2019-2030) & (K Doses)
Figure 19. Europe Follicle Stimulating Hormone Sales YoY (2019-2030) & (K Doses)
Figure 20. China Follicle Stimulating Hormone Sales YoY (2019-2030) & (K Doses)
Figure 21. Asia (Excluding China) Follicle Stimulating Hormone Sales YoY (2019-2030) & (K Doses)
Figure 22. Middle East, Africa and Latin America (Excluding China) Follicle Stimulating Hormone Sales YoY (2019-2030) & (K Doses)
Figure 23. Global Follicle Stimulating Hormone Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Follicle Stimulating Hormone Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Follicle Stimulating Hormone Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Follicle Stimulating Hormone Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Follicle Stimulating Hormone Revenue Market Share by Type (2019-2030)
Figure 29. Global Follicle Stimulating Hormone Sales by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 30. Global Follicle Stimulating Hormone Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global Follicle Stimulating Hormone Sales Market Share by Type (2019-2030)
Figure 32. Global Follicle Stimulating Hormone Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 33. Global Follicle Stimulating Hormone Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 34. Global Follicle Stimulating Hormone Revenue Market Share by Application (2019-2030)
Figure 35. Global Follicle Stimulating Hormone Sales by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 36. Global Follicle Stimulating Hormone Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global Follicle Stimulating Hormone Sales Market Share by Application (2019-2030)
Figure 38. North America Follicle Stimulating Hormone Revenue Share by Type (2019-2030)
Figure 39. North America Follicle Stimulating Hormone Sales Share by Type (2019-2030)
Figure 40. North America Follicle Stimulating Hormone Revenue Share by Application (2019-2030)
Figure 41. North America Follicle Stimulating Hormone Sales Share by Application (2019-2030)
Figure 42. North America Follicle Stimulating Hormone Revenue Share by Country (2019-2030)
Figure 43. North America Follicle Stimulating Hormone Sales Share by Country (2019-2030)
Figure 44. Europe Follicle Stimulating Hormone Revenue Share by Type (2019-2030)
Figure 45. Europe Follicle Stimulating Hormone Sales Share by Type (2019-2030)
Figure 46. Europe Follicle Stimulating Hormone Revenue Share by Application (2019-2030)
Figure 47. Europe Follicle Stimulating Hormone Sales Share by Application (2019-2030)
Figure 48. Europe Follicle Stimulating Hormone Revenue Share by Country (2019-2030)
Figure 49. Europe Follicle Stimulating Hormone Sales Share by Country (2019-2030)
Figure 50. China Follicle Stimulating Hormone Revenue Share by Type (2019-2030)
Figure 51. China Follicle Stimulating Hormone Sales Share by Type (2019-2030)
Figure 52. China Follicle Stimulating Hormone Revenue Share by Application (2019-2030)
Figure 53. China Follicle Stimulating Hormone Sales Share by Application (2019-2030)
Figure 54. Asia Follicle Stimulating Hormone Revenue Share by Type (2019-2030)
Figure 55. Asia Follicle Stimulating Hormone Sales Share by Type (2019-2030)
Figure 56. Asia Follicle Stimulating Hormone Revenue Share by Application (2019-2030)
Figure 57. Asia Follicle Stimulating Hormone Sales Share by Application (2019-2030)
Figure 58. Asia Follicle Stimulating Hormone Revenue Share by Country (2019-2030)
Figure 59. Asia Follicle Stimulating Hormone Sales Share by Country (2019-2030)
Figure 60. MEALA Follicle Stimulating Hormone Revenue Share by Type (2019-2030)
Figure 61. MEALA Follicle Stimulating Hormone Sales Share by Type (2019-2030)
Figure 62. MEALA Follicle Stimulating Hormone Revenue Share by Application (2019-2030)
Figure 63. MEALA Follicle Stimulating Hormone Sales Share by Application (2019-2030)
Figure 64. MEALA Follicle Stimulating Hormone Revenue Share by Country (2019-2030)
Figure 65. MEALA Follicle Stimulating Hormone Sales Share by Country (2019-2030)
Figure 66. Follicle Stimulating Hormone Value Chain
Figure 67. Manufacturing Cost Structure
Figure 68. Follicle Stimulating Hormone Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
